Why the study?
Despite significant improvement in acute ischemic stroke prognosis with reperfusion therapy, the rate of functional independence remains limited, creating a need to identify risk factors and develop a predictive model for poor prognosis after thrombolysis or thrombectomy.
Does a predictive model based on NIHSS score and PhenoAge Acceleration predict poor prognosis in acute ischemic stroke patients after thrombolysis/thrombectomy?
Does a predictive model based on NIHSS score and PhenoAge Acceleration predict poor prognosis in acute ischemic stroke patients after thrombolysis/thrombectomy?
A predictive nomogram combining NIHSS score and PhenoAge Acceleration effectively predicts poor prognosis (AUC 0.82) in acute ischemic stroke patients undergoing thrombolysis or thrombectomy.
Answers are grounded in this paper and cite their sources.
May refine post-reperfusion prognosis assessment in AIS; leaves open external validation before clinical use.
Acute ischemic stroke (AIS) is a leading cause of death and disability worldwide. Despite the significant improvement in prognosis with reperfusion therapy, the rate of functional independence remains limited. This study aims to identify risk factors for poor prognosis after thrombolysis/thrombectomy and develop a predictive model to enhance the accuracy of prognosis assessment. A retrospective analysis was conducted on 138 patients with AIS who received thrombolysis/thrombectomy at Shanghai Sixth People’s Hospital Fujian between February 2021 and September 2024. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors. The nomogram model was constructed using R software and validated internally. ROC curve analysis, Hosmer–Lemeshow goodness-of-fit test (HL), and decision curve analysis (DCA) were used to assess model performance. Results Among the 138 patients, 75 (54.35%) had poor prognosis. Multivariate analysis revealed that the National Institutes of Health Stroke Scale (NIHSS) score (OR = 1.105, 95% CI 1.038–1.177, P = 0.002) and PhenoAge Acceleration (PhenoAgeAccel) (OR = 1.118, 95% CI 1.030–1.212, P = 0.007) were independent predictors of poor prognosis. The nomogram model demonstrated an area under the curve (AUC) of 0.82 in both the training and validation groups. The HL indicated good model fit ( P = 0.116), and DCA results confirmed the model's clinical utility. Conclusions The predictive model based on NIHSS score and PhenoAgeAccel effectively predicts poor prognosis in patients with AIS following thrombolysis/thrombectomy. This model can help identify high-risk patients early and inform personalized treatment strategies. Further validation in larger, multicenter studies is needed to confirm its broad applicability.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: